Internal Products - Aganocide® Compounds

Indication Market Clinical Status 

Urinary Catheter Blockage and Encrustation (UCBE)
to prevent Urinary Tract Infections (UTIs)

 ~300,000 permanently catheterized patients Phase 2

Ophthalmic
(Lead indication)

5M annual cases of conjunctivitis

Phase 2
Onychomycosis
(fungal nail infection)		 30M patients Pre-Clinical

Internal Products - NeutroPhase®

Indication Market Clinical Status 

Wound healing

 6M annual cases of chronic non-healing wounds Two FDA 510(k) clearances

Novabay